These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11679979)

  • 1. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke.
    Shah V
    Hepatology; 2001 Nov; 34(5):1060-1. PubMed ID: 11679979
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
    Hennenberg M; Trebicka J; Buecher D; Heller J; Sauerbruch T
    Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
    Sogni P; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy in rats with biliary cirrhosis.
    Inserte J; Perelló A; Agulló L; Ruiz-Meana M; Schlüter KD; Escalona N; Graupera M; Bosch J; Garcia-Dorado D
    Hepatology; 2003 Sep; 38(3):589-98. PubMed ID: 12939585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension.
    Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1074-81. PubMed ID: 12381520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
    Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
    Iwakiri Y; Groszmann RJ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S121-31. PubMed ID: 16447289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular effects of cannabinoids].
    Járai Z; Kúnos G
    Orv Hetil; 2002 Jun; 143(26):1563-8. PubMed ID: 12140859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.